FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory ...
Medpage Today on MSN
Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial
ATLANTA -- Oral tebipenem pivoxil (TBP-PI) was non-inferior to IV imipenem-cilastatin (IMI-CIL) for treating complicated ...
Q3 2025 Earnings Call Transcript October 24, 2025 General Dynamics Corporation beats earnings expectations. Reported EPS is ...
Q3 2025 Earnings Call Transcript October 24, 2025 NatWest Group plc beats earnings expectations. Reported EPS is $0.53, ...
UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback